MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Asacol (mesalamine)

Company: Procter & Gamble
Approval Status: Approved August 1997
Treatment for: ulcerative colitits
Areas: Gastrointestinal

| General Information | Side Effects |


General Information

Asacol (mesalamine) was approved by the Food and Drug Administration in August 1997. Asacol tablets are indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.


Side Effects

Side effects include headaches, abdominal pain, eructation, and nausea.




< back to top

Asacol Drug Information

The Asacol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.